Zhejiang Xibaishou Pharmaceutical

Zhejiang Xibaishou Pharmaceutical Co., Ltd., established in 2004 and based in Quzhou, Zhejiang, is a pharmaceutical manufacturer specializing in anti-infective medications. The company is recognized as a National High-tech Enterprise in China and holds GMP certifications for multiple dosage forms, including granules, tablets, and capsules. Its core product portfolio is centered on macrolide antibiotics, featuring prominent products such as Yan Sha (Azithromycin) and Erythromycin Ethylsuccinate. Xibaishou Pharmaceutical focuses on providing effective treatments for common infectious diseases, particularly those affecting the respiratory tract. The company operates integrated facilities for research, manufacturing, and distribution, serving as a key regional player in the Chinese pharmaceutical industry. Its business model emphasizes the production of high-quality, accessible essential medicines for the domestic market.